摘要
基质金属蛋白酶与缺血性脑血管病的发生,脑缺血后脑损伤及再灌注关系密切,基质金属蛋白酶抑制剂可能成为防治缺血性脑血管病的新靶点。
There is a close relationship between matrix metalloproteinase and the development of cerebral ischemia, as well as the following cerebral damage and reperfusion. Inhibitor of metalloproteinase can be the new target for the prevention and treatment of cerebral ischemia.
出处
《医学综述》
2006年第1期55-57,共3页
Medical Recapitulate
关键词
基质金属蛋白酶
基质金属蛋白酶抑制剂
脑缺血
Matrix metalloproteinase
Inhibitor of metalloproteinase
Cerebral ischemia